Literature DB >> 17428285

Kidney and pancreas transplantation in the United States, 1996-2005.

K A Andreoni1, K L Brayman, M K Guidinger, C M Sommers, R S Sung.   

Abstract

Kidney and pancreas transplantation in 2005 improved in quantity and outcome quality, despite the increasing average age of kidney graft recipients, with 56% aged 50 or older. Geography and ABO blood type contribute to the discrepancy in waiting time among the deceased donor (DD) candidates. Allocation policy changes are decreasing the median times to transplant for pediatric recipients. Overall, 6% more DD kidney transplants were performed in 2005 with slight increases in standard criteria donors (SCD) and expanded criteria donors (ECD). The largest increase (39%) was in donation after cardiac death (DCD) from non-ECD donors. These DCD, non-ECD kidneys had equivalent outcomes to SCD kidneys. 1-, 3- and 5-year unadjusted graft survival was 91%, 80% and 70% for non-ECD-DD transplants, 82%, 68% and 53% for ECD-DD grafts, and 95%, 88% and 80% for living donor kidney transplants. In 2005, 27% of patients were discharged without steroids compared to 3% in 1999. Acute rejection decreased to 11% in 2004. There was a slight increase in the number of simultaneous pancreas-kidney transplants (895), with fewer pancreas after kidney transplants (343 from 419 in 2004), and a stable number of pancreas alone transplants (129). Pancreas underutilization appears to be an ongoing issue.

Entities:  

Mesh:

Year:  2007        PMID: 17428285     DOI: 10.1111/j.1600-6143.2006.01781.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  39 in total

1.  Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation.

Authors:  Julio Pascual; Milagros D Samaniego; José R Torrealba; Jon S Odorico; Arjang Djamali; Yolanda T Becker; Barbara Voss; Glen E Leverson; Stuart J Knechtle; Hans W Sollinger; John D Pirsch
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

2.  The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.

Authors:  Michael M Yeboah; Md Abdul Hye Khan; Marla A Chesnik; Amit Sharma; Mahesh P Paudyal; John R Falck; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-29

Review 3.  The impact of inherited thrombophilia on surgery: a factor to consider before transplantation?

Authors:  Elias Kfoury; Ali Taher; Said Saghieh; Zaher K Otrock; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2008-05-31       Impact factor: 2.316

4.  Sacral neuromodulation enabling simultaneous pancreas and kidney transplantation: a first case.

Authors:  Donatella Pistolesi; Massimiliano Barsotti; Gianluca Giannarini; Mauro Mantovani; Ugo Boggi; Thomas M Kessler; Cesare Selli
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 5.  Effectiveness and safety of calcineurin inhibitor withdrawal in kidney transplantation: a meta-analysis of randomized controlled trials.

Authors:  Hongwei Bai; Yeyong Qian; Bingyi Shi; Zhen Wang; Gang Li; Yu Fan; Ming Yuan; Lupeng Liu
Journal:  Clin Exp Nephrol       Date:  2015-03-29       Impact factor: 2.801

6.  Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.

Authors:  Baharak Bahmani; Mayuko Uehara; Liwei Jiang; Farideh Ordikhani; Naima Banouni; Takaharu Ichimura; Zhabiz Solhjou; Georg J Furtmüller; Gerald Brandacher; David Alvarez; Ulrich H von Andrian; Kenji Uchimura; Qiaobing Xu; Ishaan Vohra; Osman A Yilmam; Yousef Haik; Jamil Azzi; Vivek Kasinath; Jonathan S Bromberg; Martina M McGrath; Reza Abdi
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

Review 7.  Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center.

Authors:  Jeffrey Rogers; Alan C Farney; Samer Al-Geizawi; Samy S Iskandar; William Doares; Michael D Gautreaux; Lois Hart; Scott Kaczmorski; Amber Reeves-Daniel; Stephanie Winfrey; Mythili Ghanta; Patricia L Adams; Robert J Stratta
Journal:  Rev Diabet Stud       Date:  2011-05-10

8.  Short-term outcome and quality of life in kidney transplant recipient with monoclonal gammopathy.

Authors:  Masaaki Yanishi; Hiroyasu Tsukaguchi; Takashi Yoshida; Hisanori Taniguchi; Kenji Yoshida; Takao Mishima; Yoshihiro Komai; Kaneki Yasuda; Masato Watanabe; Motohiko Sugi; Hidefumi Kinoshita; Tadashi Matsuda
Journal:  CEN Case Rep       Date:  2016-04-05

9.  Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantation.

Authors:  Kellee Bornemann; Emilee Croswell; Menna Abaye; Cindy L Bryce; Chung-Chou H Chang; Deborah S Good; Cathleen A Freehling Heiles; Mary Amanda Dew; L Ebony Boulware; Amit D Tevar; Larissa Myaskovsky
Journal:  Contemp Clin Trials       Date:  2016-12-05       Impact factor: 2.226

10.  Pancreas transplantation: differences in activity between Europe and the United States.

Authors:  José Manuel González-Posada; Domingo Marrero; Domingo Hernández; Elisabeth Coll; Lourdes Pérez Tamajón; Pedro Gutiérrez; Eduardo Martín; Alberto Bravo; Antonio Alarcó; Rafael Matesanz
Journal:  Nephrol Dial Transplant       Date:  2009-11-17       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.